Adjuvant radiotherapy in patients with high-risk cutaneous Squamous Cell Carcinoma After surgery (SCC-AFTER): Patient and carer views regarding a proposed clinical trial

Chidiebere Nwolise; Agata Rembielak; Ray Fitzpatrick; Crispin Jenkinson; Jerry Marsden; Patricia Fairbrother; Charlotte M. Proby; Catherine A. Harwood; Rubeta N. Matin

doi:10.1111/ced.15300

Adjuvant radiotherapy in patients with high-risk cutaneous Squamous Cell Carcinoma After surgery (SCC-AFTER): Patient and carer views regarding a proposed clinical trial

Chidiebere Nwolise (Lead / Corresponding author)
, Agata Rembielak
, Ray Fitzpatrick
, Crispin Jenkinson
, Jerry Marsden
, Patricia Fairbrother
, Charlotte M. Proby
, Catherine A. Harwood
, Rubeta N. Matin

Research output: Contribution to journal › Letter › peer-review

1 Citation (Scopus)

86 Downloads (Pure)

Original language	English
Pages (from-to)	1875-1876
Number of pages	2
Journal	Clinical and Experimental Dermatology
Volume	47
Issue number	10
Early online date	20 Jun 2022
DOIs	https://doi.org/10.1111/ced.15300
Publication status	Published - Oct 2022

Access to Document

10.1111/ced.15300

Author Accepted ManuscriptAccepted author manuscript, 262 KB

Cite this

Nwolise, C., Rembielak, A., Fitzpatrick, R., Jenkinson, C., Marsden, J., Fairbrother, P., Proby, C. M., Harwood, C. A., & Matin, R. N. (2022). Adjuvant radiotherapy in patients with high-risk cutaneous Squamous Cell Carcinoma After surgery (SCC-AFTER): Patient and carer views regarding a proposed clinical trial. Clinical and Experimental Dermatology, 47(10), 1875-1876. https://doi.org/10.1111/ced.15300

@article{bbeebed8d3c542f6aa4b78624f005381,

title = "Adjuvant radiotherapy in patients with high-risk cutaneous Squamous Cell Carcinoma After surgery (SCC-AFTER): Patient and carer views regarding a proposed clinical trial",

author = "Chidiebere Nwolise and Agata Rembielak and Ray Fitzpatrick and Crispin Jenkinson and Jerry Marsden and Patricia Fairbrother and Proby, \{Charlotte M.\} and Harwood, \{Catherine A.\} and Matin, \{Rubeta N.\}",

note = "Funding Information: This project was developed with support from the UK Dermatology Clinical Trials Network (UK DCTN). The authors gratefully acknowledge the Themed Call Funding received from the UK DCTN to carry out this patient and public involvement consultation. The UK DCTN is grateful to the British Association of Dermatologists (BAD) and the University of Nottingham for financial support of the Network. Copyright Information: {\textcopyright} 2022 British Association of Dermatologists.",

year = "2022",

month = oct,

doi = "10.1111/ced.15300",

language = "English",

volume = "47",

pages = "1875--1876",

journal = "Clinical and Experimental Dermatology",

issn = "0307-6938",

publisher = "Oxford University Press",

number = "10",

}

Nwolise, C, Rembielak, A, Fitzpatrick, R, Jenkinson, C, Marsden, J, Fairbrother, P, Proby, CM, Harwood, CA & Matin, RN 2022, 'Adjuvant radiotherapy in patients with high-risk cutaneous Squamous Cell Carcinoma After surgery (SCC-AFTER): Patient and carer views regarding a proposed clinical trial', Clinical and Experimental Dermatology, vol. 47, no. 10, pp. 1875-1876. https://doi.org/10.1111/ced.15300

Adjuvant radiotherapy in patients with high-risk cutaneous Squamous Cell Carcinoma After surgery (SCC-AFTER): Patient and carer views regarding a proposed clinical trial. / Nwolise, Chidiebere (Lead / Corresponding author); Rembielak, Agata; Fitzpatrick, Ray et al.
In: Clinical and Experimental Dermatology, Vol. 47, No. 10, 10.2022, p. 1875-1876.

Research output: Contribution to journal › Letter › peer-review

TY - JOUR

T1 - Adjuvant radiotherapy in patients with high-risk cutaneous Squamous Cell Carcinoma After surgery (SCC-AFTER)

T2 - Patient and carer views regarding a proposed clinical trial

AU - Nwolise, Chidiebere

AU - Rembielak, Agata

AU - Fitzpatrick, Ray

AU - Jenkinson, Crispin

AU - Marsden, Jerry

AU - Fairbrother, Patricia

AU - Proby, Charlotte M.

AU - Harwood, Catherine A.

AU - Matin, Rubeta N.

N1 - Funding Information: This project was developed with support from the UK Dermatology Clinical Trials Network (UK DCTN). The authors gratefully acknowledge the Themed Call Funding received from the UK DCTN to carry out this patient and public involvement consultation. The UK DCTN is grateful to the British Association of Dermatologists (BAD) and the University of Nottingham for financial support of the Network. Copyright Information: © 2022 British Association of Dermatologists.

PY - 2022/10

Y1 - 2022/10

U2 - 10.1111/ced.15300

DO - 10.1111/ced.15300

M3 - Letter

C2 - 35722934

SN - 0307-6938

VL - 47

SP - 1875

EP - 1876

JO - Clinical and Experimental Dermatology

JF - Clinical and Experimental Dermatology

IS - 10

ER -